Avalo Therapeutics
AVTX
AVTX
20 hedge funds and large institutions have $68.3M invested in Avalo Therapeutics in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
19% less capital invested
Capital invested by funds: $84.7M → $68.3M (-$16.5M)
Holders
20
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$6.21M | |
| 2 | +$2.03M | |
| 3 | +$994K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$668K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$102K |
Top Sellers
| 1 | -$150K | |
| 2 | -$93K | |
| 3 | -$81.7K | |
| 4 |
Goldman Sachs
New York
|
-$81K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$56.2K |